Bourdeaux A M, Nordmann R, Giudicelli Y
FEBS Lett. 1984 Dec 3;178(1):132-6. doi: 10.1016/0014-5793(84)81256-9.
Adenosine and its 'Ri'- and 'P'-site analogs, N6-phenylisopropyladenosine and 2'-deoxyadenosine, stimulate, like insulin, lipoprotein lipase (LPL) activity in adipose tissue, an effect which is suppressed by cycloheximide. However, adenosine and its analogs do not potentiate the effects of submaximal insulin concentrations. As addition of cyclic AMP phosphodiesterase inhibitors abolishes the LPL stimulatory effects of insulin, adenosine and its analogs, this study suggests that these LPL effects are mediated through common mechanisms which are likely a decrease in cyclic AMP and an increase in LPL biosynthesis.
腺苷及其“Ri”和“P”位点类似物,N6-苯基异丙基腺苷和2'-脱氧腺苷,与胰岛素一样,能刺激脂肪组织中的脂蛋白脂肪酶(LPL)活性,环己酰亚胺可抑制这一效应。然而,腺苷及其类似物不会增强次最大胰岛素浓度的作用。由于添加环磷酸腺苷磷酸二酯酶抑制剂可消除胰岛素、腺苷及其类似物对LPL的刺激作用,本研究表明,这些LPL效应是通过共同机制介导的,这些机制可能是环磷酸腺苷减少和LPL生物合成增加。